Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucia Trudu

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Lung Cancer (Amsterdam, Netherlands)|August 16, 2025
CAR-T for Lung Cancers: Challenges and InnovationsLucia Trudu, Giulia Rovesti, Giovanni Neri, et al.
British Journal of Cancer|December 2, 2022
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
British Journal of Cancer|November 17, 2022
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
NPJ Precision Oncology|February 1, 2024
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastomaChiara Chiavelli, Malvina Prapa, Giulia Rovesti, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Lung Cancer (Amsterdam, Netherlands)|August 16, 2025
CAR-T for Lung Cancers: Challenges and InnovationsLucia Trudu, Giulia Rovesti, Giovanni Neri, et al.
British Journal of Cancer|December 2, 2022
Correction: Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
British Journal of Cancer|November 17, 2022
Incorporating weekly carboplatin in anthracycline and paclitaxel-containing neoadjuvant chemotherapy for triple-negative breast cancer: propensity-score matching analysis and TIL evaluationMaria Vittoria Dieci, Luisa Carbognin, Federica Miglietta, et al.
NPJ Precision Oncology|February 1, 2024
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastomaChiara Chiavelli, Malvina Prapa, Giulia Rovesti, et al.
Pageof 2